Atricure Inc. buy Needham & Company LLC
Start price
30.07.25
/
50%
€29.29
Target price
30.07.26
€38.90
Performance (%)
-8.50%
Price
18.02.26
€27.40
Summary
This prediction is currently active. With a performance of -8.50%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 30.07.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | - | - |
| iShares Core DAX® | 1.066% | -0.525% |
| iShares Nasdaq 100 | -0.493% | -4.055% |
| iShares Nikkei 225® | -2.028% | 6.911% |
| iShares S&P 500 | -0.103% | -2.366% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat